Quantcast
Last updated on April 19, 2014 at 8:45 EDT

Latest Purdue Pharma Stories

2014-04-01 08:28:22

MONMOUTH JUNCTION, N.J., April 1, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced several key management changes, including the new appointment of Mr. Stephen J. Kovary to the position of Vice President of Operations. Mr. Kovary brings three decades of pharmaceutical experience in the areas of manufacturing, process improvement, facilities, engineering, plant and systems management. Prior to...

2014-03-12 08:30:24

Investigational Opioid Analgesic Incorporates Abuse-Deterrent Technology STAMFORD, Conn., March 12, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that a Phase 3 study of an investigational extended-release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once-daily analgesic agent experienced statistically significant reduction in pain compared with placebo (p=0.0016). This investigational...

2014-02-14 16:25:45

DUBLIN, February 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pdhgfs/pain_management) has announced the addition of the "Pain Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/pdhgfs/pain_management ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global pain management...

2014-02-04 20:22:43

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/f3g6bf/pain_management) has announced the addition of the "Concise Analysis on the International Pain Management Treatment Markets" [http://www.researchandmarkets.com/research/f3g6bf/pain_management ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Pain management describes a particular set of drugs, analgesics, which...

2014-01-28 23:29:46

Passages Malibu CEO issues statement on the FDA Approval of Zohydro. Malibu, CA (PRWEB) January 28, 2014 The Food and Drug Administration (FDA) recently approved the sale of Zohydro ER, an extended release version of hydrocodone developed and manufactured by Zogenix. Following that approval, on December 12th 2013, attorneys general from 27 states and the US territory of Guam issued a letter, asking the FDA to reconsider its green light of the drug. A panel hired by the FDA voted 11-2...

2014-01-27 08:27:48

STAMFORD, Conn., Jan. 27, 2014 /PRNewswire/ -- Purdue Pharma L.P. today announced that the company's Board of Directors has appointed Mark Timney as President and Chief Executive Officer. "We found a proven leader in Mark Timney," said Dr. Raymond Sackler, co-founder and board member of Purdue. "I am confident that his capabilities and experience, coupled with Purdue's culture of excellence, will grow our business and strengthen our healthcare industry leadership." Mark brings more...

2013-12-23 08:24:13

DUBLIN, December 23, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/x7lkkh/pain_management) has announced the addition of the "2013 Report on the International Pain Management Therapeutics Market - Includes Forecast to 2018" [http://www.researchandmarkets.com/research/x7lkkh/pain_management ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The various pain management indications studied...

2013-12-05 23:04:28

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) December 05, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals....

2013-12-05 12:25:28

Comprehensive review of pharma websites and patient support programs helps marketers plan more competitive digital initiatives - client-only webinar Dec. 17 at 11am ET NEW YORK, Dec. 5, 2013 /PRNewswire/ -- With patients increasingly searching for medical information on their smartphones, surprisingly few websites for prescription pharmaceuticals are ready for them. Just 28 percent of the 160 pharma-owned websites reviewed in Manhattan Research's new ePharma Competitive Analysis Series were...

2013-12-03 08:33:07

STAMFORD, Conn., Dec. 3, 2013 /PRNewswire/ -- Purdue Pharma L.P. and Impax Laboratories, Inc. announced today that the companies have agreed to resolve the patent infringement lawsuits between them now pending in the United States District Court for the Southern District of New York concerning certain Purdue patents, including patents for abuse-deterrent technology, protecting OxyContin® (oxycodone HCl controlled-release) Tablets CII ("OxyContin"). According to the agreement, Purdue and...